<VariationArchive VariationID="213492" VariationName="NM_001110556.2(FLNA):c.2190_2193del (p.Tyr731fs)" VariationType="Deletion" Accession="VCV000213492" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-27" DateCreated="2015-10-11" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="210513" VariationID="213492">
      <GeneList>
        <Gene Symbol="FLNA" FullName="filamin A" GeneID="2316" HGNC_ID="HGNC:3754" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154348531" stop="154374634" display_start="154348531" display_stop="154374634" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153576899" stop="153603005" display_start="153576899" display_stop="153603005" Strand="-" />
          </Location>
          <OMIM>300017</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FLNA">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FLNA">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001110556.2(FLNA):c.2190_2193del (p.Tyr731fs)</Name>
      <CanonicalSPDI>NC_000023.11:154364108:GTAAGT:GT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154364109" stop="154364112" display_start="154364109" display_stop="154364112" variantLength="4" positionVCF="154364108" referenceAlleleVCF="TGTAA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153592477" stop="153592480" display_start="153592477" display_stop="153592480" variantLength="4" positionVCF="153592476" referenceAlleleVCF="TGTAA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>Y731fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153592479_153592482del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153592479_153592482del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154364111_154364114del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154364111_154364114del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011506.2" sequenceAccession="NG_011506" sequenceVersion="2" change="g.15527_15530del">
            <Expression>NG_011506.2:g.15527_15530del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001110556.2" sequenceAccession="NM_001110556" sequenceVersion="2" change="c.2190_2193del" MANESelect="true">
            <Expression>NM_001110556.2:c.2190_2193del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001104026.1" sequenceAccession="NP_001104026" sequenceVersion="1" change="p.Tyr731fs">
            <Expression>NP_001104026.1:p.Tyr731fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001456.4" sequenceAccession="NM_001456" sequenceVersion="4" change="c.2190_2193del">
            <Expression>NM_001456.4:c.2190_2193del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001447.2" sequenceAccession="NP_001447" sequenceVersion="2" change="p.Tyr731fs">
            <Expression>NP_001447.2:p.Tyr731fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1340" sequenceAccession="LRG_1340">
            <Expression>LRG_1340:g.15527_15530del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1340t1" sequenceAccession="LRG_1340t1">
            <Expression>LRG_1340t1:c.2190_2193del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1340p1" sequenceAccession="LRG_1340p1" change="p.Tyr731fs">
            <Expression>LRG_1340p1:p.Tyr731fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001456.3" sequenceAccession="NM_001456" sequenceVersion="3" change="c.2190_2193delTTAC">
            <Expression>NM_001456.3:c.2190_2193delTTAC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA320241" DB="ClinGen" />
        <XRef Type="rs" ID="863223630" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001110556.2(FLNA):c.2190_2193del (p.Tyr731fs) AND not provided" Accession="RCV000195861" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-02-16" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001110556.2(FLNA):c.2190_2193del (p.Tyr731fs) AND multiple conditions" Accession="RCV002517180" Version="2">
        <ClassifiedConditionList TraitSetID="53144">
          <ClassifiedCondition DB="MedGen" ID="C0265293">Frontometaphyseal dysplasia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1848213">Heterotopia, periventricular, X-linked dominant</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0025237">Melnick-Needles syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1844696">Oto-palato-digital syndrome, type II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-11" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-10-11" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16684786</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20730588</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26471271</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28898549</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-08-19">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="53144" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2842" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Melnick-Needles osteodysplasty</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteodysplasty of Melnick and Needles</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Melnick-Needles syndrome</ElementValue>
                <XRef ID="Melnick-Needles+syndrome/4587" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010650" DB="MONDO" />
                <XRef ID="13449007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MNS</ElementValue>
                <XRef Type="MIM" ID="309350" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">FLNA-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The X-linked otopalatodigital (X-OPD) spectrum disorders, characterized primarily by skeletal dysplasia, include the following: Otopalatodigital syndrome type 1 (OPD1). Otopalatodigital syndrome type 2 (OPD2). Frontometaphyseal dysplasia type 1 (FMD1). Melnick-Needles syndrome (MNS). Terminal osseous dysplasia with pigmentary skin defects (TODPD). In OPD1, most manifestations are present at birth; females can present with severity similar to affected males, although some have only mild manifestations. In OPD2, females are less severely affected than related affected males. Most males with OPD2 die during the first year of life, usually from thoracic hypoplasia resulting in pulmonary insufficiency. Males who live beyond the first year of life are usually developmentally delayed and require respiratory support and assistance with feeding. In FMD1, females are less severely affected than related affected males. Males do not experience a progressive skeletal dysplasia but may have joint contractures and hand and foot malformations. Progressive scoliosis is observed in both affected males and females. In MNS, wide phenotypic variability is observed; some individuals are diagnosed in adulthood, while others require respiratory support and have reduced longevity. MNS in males results in perinatal lethality in all recorded cases. TODPD, seen only in females, is characterized by a skeletal dysplasia that is most prominent in the digits, pigmentary defects of the skin, and recurrent digital fibromata.</Attribute>
                <XRef ID="NBK1393" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7011" />
                <XRef ID="7011" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301567</ID>
                <ID Source="BookShelf">NBK1393</ID>
              </Citation>
              <XRef ID="2484" DB="Orphanet" />
              <XRef ID="C0025237" DB="MedGen" />
              <XRef ID="MONDO:0010650" DB="MONDO" />
              <XRef Type="MIM" ID="309350" DB="OMIM" />
            </Trait>
            <Trait ID="3340" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Otopalatodigital Syndrome, Type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andre syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OPD 2 syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cranio-oro-digital syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Faciopalatoosseous syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OPD II SYNDROME</ElementValue>
                <XRef Type="MIM" ID="304120" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oto-palato-digital syndrome type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Oto-palato-digital syndrome, type II</ElementValue>
                <XRef ID="Oto-palato-digital+syndrome+type+2/5496" DB="Genetic Alliance" />
                <XRef ID="42432003" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FPO</ElementValue>
                <XRef Type="MIM" ID="304120" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">OPD2</ElementValue>
                <XRef Type="MIM" ID="304120" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5802" />
                <XRef ID="5802" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FLNA-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The X-linked otopalatodigital (X-OPD) spectrum disorders, characterized primarily by skeletal dysplasia, include the following: Otopalatodigital syndrome type 1 (OPD1). Otopalatodigital syndrome type 2 (OPD2). Frontometaphyseal dysplasia type 1 (FMD1). Melnick-Needles syndrome (MNS). Terminal osseous dysplasia with pigmentary skin defects (TODPD). In OPD1, most manifestations are present at birth; females can present with severity similar to affected males, although some have only mild manifestations. In OPD2, females are less severely affected than related affected males. Most males with OPD2 die during the first year of life, usually from thoracic hypoplasia resulting in pulmonary insufficiency. Males who live beyond the first year of life are usually developmentally delayed and require respiratory support and assistance with feeding. In FMD1, females are less severely affected than related affected males. Males do not experience a progressive skeletal dysplasia but may have joint contractures and hand and foot malformations. Progressive scoliosis is observed in both affected males and females. In MNS, wide phenotypic variability is observed; some individuals are diagnosed in adulthood, while others require respiratory support and have reduced longevity. MNS in males results in perinatal lethality in all recorded cases. TODPD, seen only in females, is characterized by a skeletal dysplasia that is most prominent in the digits, pigmentary defects of the skin, and recurrent digital fibromata.</Attribute>
                <XRef ID="NBK1393" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301567</ID>
                <ID Source="BookShelf">NBK1393</ID>
              </Citation>
              <XRef ID="669" DB="Orphanet" />
              <XRef ID="90652" DB="Orphanet" />
              <XRef ID="C1844696" DB="MedGen" />
              <XRef ID="MONDO:0010571" DB="MONDO" />
              <XRef Type="MIM" ID="304120" DB="OMIM" />
            </Trait>
            <Trait ID="43500" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Frontometaphyseal dysplasia</ElementValue>
                <XRef ID="Frontometaphyseal+Dysplasia/2937" DB="Genetic Alliance" />
                <XRef ID="MONDO:0015942" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS305620" DB="OMIM" />
                <XRef ID="62803002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FMD1</ElementValue>
                <XRef ID="GTR000519546" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FMD</ElementValue>
                <XRef Type="MIM" ID="305620" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="826" />
                <XRef ID="826" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1826" DB="Orphanet" />
              <XRef ID="C0265293" DB="MedGen" />
              <XRef ID="MONDO:0015942" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS305620" DB="OMIM" />
            </Trait>
            <Trait ID="1645" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Heterotopia, periventricular, X-linked dominant</ElementValue>
                <XRef ID="MONDO:0010233" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Heterotopia familial nodular</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nodular heterotopia bilateral periventricular</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PERIVENTRICULAR NODULAR HETEROTOPIA 1</ElementValue>
                <XRef Type="MIM" ID="300049" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked periventricular heterotopia</ElementValue>
                <XRef ID="X-linked+periventricular+heterotopia/7556" DB="Genetic Alliance" />
                <XRef ID="448227009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PERIVENTRICULAR NODULAR HETEROTOPIA 4</ElementValue>
                <XRef Type="MIM" ID="300537" DB="OMIM" />
                <XRef Type="MIM" ID="300049" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HETEROTOPIA, PERIVENTRICULAR, 1</ElementValue>
                <XRef Type="Allelic variant" ID="300017.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300017.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300017.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300017.0021" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NHBP</ElementValue>
                <XRef Type="MIM" ID="300049" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BPNH</ElementValue>
                <XRef Type="MIM" ID="300049" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PVNH1</ElementValue>
                <XRef Type="MIM" ID="300049" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PVNH4</ElementValue>
                <XRef Type="MIM" ID="300049" DB="OMIM" />
                <XRef Type="MIM" ID="300537" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7371" />
                <XRef ID="7371" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FLNA-Related Periventricular Nodular Heterotopia</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">FLNA deficiency is associated with a phenotypic spectrum that includes FLNA-related periventricular nodular heterotopia (Huttenlocher syndrome), congenital heart disease (patent ductus arteriosus, atrial and ventricular septal defects), valvular dystrophy, dilation and rupture of the thoracic aortic, pulmonary disease (pulmonary hypertension, alveolar hypoplasia, emphysema, asthma, chronic bronchitis), gastrointestinal dysmotility and obstruction, joint hypermobility, and macrothrombocytopenia.</Attribute>
                <XRef ID="NBK1213" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FLNA-Related Disorders</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301392</ID>
                <ID Source="BookShelf">NBK1213</ID>
              </Citation>
              <XRef ID="2149" DB="Orphanet" />
              <XRef ID="82004" DB="Orphanet" />
              <XRef ID="C1848213" DB="MedGen" />
              <XRef ID="MONDO:0010233" DB="MONDO" />
              <XRef Type="MIM" ID="300049" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="465498" SubmissionDate="2019-01-29" DateLastUpdated="2015-10-11" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="GDX:22541|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000250410" DateUpdated="2015-10-11" DateCreated="2015-10-11" Type="SCV" Version="12" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-02-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Although the c.2190_2193delTTAC likely pathogenic variant in the FLNA gene has not been reported to our knowledge, this variant causes a shift in reading frame starting at codon tyrosine (Y) 731, changing it to an alanine (A), and creating a premature stop codon at position 10 of the new reading frame, denoted p.Tyr731AlafsX10. This likely pathogenic variant is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. Multiple frameshift and nonsense variants in the FLNA gene have been reported in the Human Gene Mutation Database in association with PH (Stenson et al., 2014), indicating that loss of function is a mechanism of disease for this gene. Furthermore, this variant has been identified in one other individual referred to GeneDx for Marfan/TAAD testing, while this variant has not been observed in large general population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). In summary, c.2190_2193delTTAC in the FLNA gene is interpreted as a likely pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLNA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001456.3:c.2190_2193delTTAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6173555" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="7133233|MedGen:C1844696;C1848213;C0265293;C0025237" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003484218" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28898549</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16684786</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20730588</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26471271</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 213492). This premature translational stop signal has been observed in individual(s) with FLNA-related conditions (PMID: 28898549). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr731Alafs*10) in the FLNA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FLNA are known to be pathogenic (PMID: 16684786, 20730588, 26471271).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLNA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.153592477_153592480del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1844696" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1848213" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265293" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0025237" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6173555" TraitType="Disease" MappingType="XRef" MappingValue="C0265293" MappingRef="MedGen">
        <MedGen CUI="C0265293" Name="Frontometaphyseal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="465498" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6173555" TraitType="Disease" MappingType="XRef" MappingValue="C1844696" MappingRef="MedGen">
        <MedGen CUI="C1844696" Name="Oto-palato-digital syndrome, type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6173555" TraitType="Disease" MappingType="XRef" MappingValue="C0025237" MappingRef="MedGen">
        <MedGen CUI="C0025237" Name="Melnick-Needles syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6173555" TraitType="Disease" MappingType="XRef" MappingValue="C1848213" MappingRef="MedGen">
        <MedGen CUI="C1848213" Name="Heterotopia, periventricular, X-linked dominant" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

